New crypto contender: Injective, Stacks, Celestia traders move to DTX Exchange
Disclosure: This article does not represent investment advice. The content and materials featured on this page are for educational purposes only.
DTX exchange presale gains strong attention from Injective, Stacks, and Celestia traders.
Finding crypto gems in the market can bring big returns in the future. A new project called DTX Exchange (DTX) is making everyone talk about it, even people who own crypto coins like Injective (INJ), Stacks (STX) and Celestia (TIA). DTX is still new, but it’s already getting much attention.
Now in Stage 2 of its presale, this token has already given those who bought it early a 100% ROI. Market analysts are also confident in its growth. They hint that DTX may soar by 150x in 2024.
Injective: A new milestone
Injective is a crypto that has seen some exciting events. Recently, Injective revealed that it burned $344,478 worth of INJ in just seven days. This is one of the highest burn auction days since its launch. With this Injective news, many people expect that the price of its token may rise soon.
The Injective crypto saw a price jump of over 110% in the past 12 months. Plus, around 15 technical signals are now showing green for INJ. Because of this, market analysts say that Injective will reach a value of $18.50 soon.
Stacks: A sleeping giant
Meanwhile, Stacks is seeing green price charts. CoinMarketCap statistics show that the Stacks price pumped nearly 150% on the YTD chart. Analyst Crypto Queen says that this price movement will keep going. In her X post, she says that STX is a sleeping giant and that the big Nakamoto update will cause a pump soon.
The Stacks coin is currently sitting above its $0.66 200-day exponential moving average. Experts in this space say that this coin will cost $1.90 in September 2024, per their Stacks price prediction.
Celestia: Big upgrade incoming
Celestia (TIA) has also been seeing some events gaining attention. Recently, Celestia revealed that Lemongrass, its first upgrade, is coming. Lemongrass brings 1-click TIA interactions with other Interchain accounts and IBC chains with this upgrade.
This Celestia news could make many people excited about its crypto. On the YTD chart, the Celestia crypto value jumped over 160%. Plus, around 13 technical signals are showing buy signs for TIA. Because of this, experts say that Celestia will cost $6.07 in September 2024.
DTX Exchange: Great ongoing presale event
DTX Exchange is slowly becoming a popular coin. Millions of people are rushing to buy it in its presale. It has already raised over $1.2m and DTX Exchange expects this number to hit $2m soon. Even big crypto names like Crypto Chino see it as a promising trading platform.
This new trading platform will combine the best of DEX and CEX into one. With this combination, people can buy or sell CFDs, bonds and cryptos at leverages of 1000x. This can be done in complete privacy as DTX Exchange does not require sign-up KYC checks. With all these advantages, DTX Exchange may become a fan favorite.
DTX Exchange has its own native utility token, DTX. Those who hold it will get many privileges, like lower trading fees and the ability to vote on governance problems. If users buy $100 of DTX in its presale, a $1m giveaway will open up. Ten people will get $100,000 apiece in this giveaway.
At the moment, DTX costs $0.04, a 100% rise from its presale launch price of $0.02. But it is expected to be worth $0.06 once Stage 3 goes live. Market analysts predict a 150x jump for DTX after it is listed on a big Tier-1 CEX in Q3 of 2024.
Why are traders paying attention to DTX Exchange?
People buying Injective, Stacks and Celestia are now turning to DTX Exchange. They are doing this because DTX has a lower market cap than these crypto coins and connections to trillion-dollar financial markets. This gives DTX an advantage since it needs less money for its price to rise while being more stable.
To learn more about DTX, visit the DTX presale, read the Whitepaper and join the DTX community.
Disclosure: This content is provided by a third party. crypto.news does not endorse any product mentioned on this page. Users must do their own research before taking any actions related to the company.